Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01062165 · ClinicalTrials.gov registry record · Phase 4
Effect of Weight and/or Obesity on Caspofungin Drug Concentrations
A Phase 4 study, sponsored by Texas Tech University Health Sciences Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 18
- Enrollment target
NCT01062165 is a Phase 4 study that has completed, run by Texas Tech University Health Sciences Center. The registered enrollment target is 18 participants.
The verdict
NCT01062165, a Phase 4 study, has completed, sponsored by Texas Tech University Health Sciences Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 18 participants
- Enrollment target
Study Summary
This study will find how weight affects the dosing of a drug called caspofungin. Currently, the amount of caspofungin a patient receives is the same regardless of the patient's weight.
Interventions
- DRUG Caspofungin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2010-02 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01062165
The ClinicalTrials.gov registry entry for NCT01062165 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Caspofungin is the first listed.
NCT01062165 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01062165 about?
NCT01062165 is a clinical study titled "Effect of Weight and/or Obesity on Caspofungin Drug Concentrations". This study will find how weight affects the dosing of a drug called caspofungin. Currently, the amount of caspofungin a patient receives is the same regardless of the patient's weight.
What is the current status of trial NCT01062165?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2010-02. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01062165?
The interventions under investigation include: Caspofungin (DRUG).
Who is sponsoring clinical trial NCT01062165?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.